Literature DB >> 26336929

Chronic high-fat feeding increases GIP and GLP-1 secretion without altering body weight.

Fei Wang1, Stephanie M Yoder1, Qing Yang1, Alison B Kohan1, Tammy L Kindel1, Jacob Wang1, Patrick Tso2.   

Abstract

The incretin hormones, glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), enhance postprandial insulin secretion, promote adipogenesis, and regulate gastrointestinal motility and food intake. To date, a consensus on how the incretin response is altered in obesity is lacking. We investigated the effects of chronic high-fat (HF) feeding on incretin secretion in the lymph fistula rat model. Male Sprague-Dawley rats (8 wk) were provided a semipurified AIN93M HF or low-fat (LF) diet ad libitum for 3 or 13 wk; a HF pair-fed (HF-PF) group was included as a control during the 3-wk feeding trial. Energy intake, body weight, and body composition were regularly monitored. At the culmination of the feeding period, an intestinal lymphatic duct cannula and duodenal infusion tube were installed. All animals were challenged with a 3-ml Ensure bolus (3.125 kcal/animal) to measure lymphatic incretin secretion. Despite a significantly higher energy intake, both the 3-wk and 13-wk HF-fed animals did not have an increase in body weight and only a slight increase in body fat compared with LF-fed rats. Following the duodenal Ensure challenge, the 3-wk and 13-wk HF-fed rats had significantly greater lymphatic GIP and GLP-1 secretion than the LF-fed animals. Additionally, the HF-PF group displayed a secretion profile similar to the HF-fed animals for GIP but a similar pattern to the LF-fed animals for GLP-1. The HF-PF data suggest that the increased GIP secretion is driven by the greater percentage of fat intake, whereas the increased GLP-1 secretion is driven by the excess caloric intake.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  glucagon-like peptide-1; glucose-dependent insulinotropic polypeptide; high-fat diet; incretin; lymph fistula rat model

Mesh:

Substances:

Year:  2015        PMID: 26336929      PMCID: PMC4652142          DOI: 10.1152/ajpgi.00351.2013

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  46 in total

1.  Metabolic differences between obesity-prone and obesity-resistant rats.

Authors:  S Chang; B Graham; F Yakubu; D Lin; J C Peters; J O Hill
Journal:  Am J Physiol       Date:  1990-12

2.  Rat small intestinal morphology and tissue regulatory peptides: effects of high dietary fat.

Authors:  F A Sagher; J A Dodge; C F Johnston; C Shaw; K D Buchanan; K E Carr
Journal:  Br J Nutr       Date:  1991-01       Impact factor: 3.718

3.  GLP-1 as a satiety factor in children with eating disorders.

Authors:  P J Tomasik; K Sztefko; A Malek
Journal:  Horm Metab Res       Date:  2002-02       Impact factor: 2.936

4.  GIP regulates glucose transporters, hexokinases, and glucose-induced insulin secretion in RIN 1046-38 cells.

Authors:  Y Wang; C Montrose-Rafizadeh; L Adams; M Raygada; O Nadiv; J M Egan
Journal:  Mol Cell Endocrinol       Date:  1996-01-15       Impact factor: 4.102

5.  Hypersecretion of truncated glucagon-like peptide-1 and gastric inhibitory polypeptide in obese patients.

Authors:  N Fukase; M Igarashi; H Takahashi; H Manaka; K Yamatani; M Daimon; M Tominaga; H Sasaki
Journal:  Diabet Med       Date:  1993 Jan-Feb       Impact factor: 4.359

6.  Further characterisation of the 'ileal brake' reflex in man--effect of ileal infusion of partial digests of fat, protein, and starch on jejunal motility and release of neurotensin, enteroglucagon, and peptide YY.

Authors:  R C Spiller; I F Trotman; T E Adrian; S R Bloom; J J Misiewicz; D B Silk
Journal:  Gut       Date:  1988-08       Impact factor: 23.059

7.  A role for glucagon-like peptide-1 in the central regulation of feeding.

Authors:  M D Turton; D O'Shea; I Gunn; S A Beak; C M Edwards; K Meeran; S J Choi; G M Taylor; M M Heath; P D Lambert; J P Wilding; D M Smith; M A Ghatei; J Herbert; S R Bloom
Journal:  Nature       Date:  1996-01-04       Impact factor: 49.962

8.  Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.

Authors:  M A Nauck; M M Heimesaat; C Orskov; J J Holst; R Ebert; W Creutzfeldt
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

9.  Plasma glucagon-like peptide-1 (GLP-1) responses to duodenal fat and glucose infusions in lean and obese men.

Authors:  Christine Feinle; Ian M Chapman; Judith Wishart; Michael Horowitz
Journal:  Peptides       Date:  2002-08       Impact factor: 3.750

10.  Stimulation of incretin secretion by dietary lipid: is it dose dependent?

Authors:  Stephanie M Yoder; Qing Yang; Tammy L Kindel; Patrick Tso
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-06-11       Impact factor: 4.052

View more
  6 in total

1.  Glycemic effect of pancreatic preproglucagon in mouse sleeve gastrectomy.

Authors:  Ki-Suk Kim; Chelsea R Hutch; Landon Wood; Irwin J Magrisso; Randy J Seeley; Darleen A Sandoval
Journal:  JCI Insight       Date:  2019-10-17

2.  Glucagon-like peptide-1 regulates brown adipose tissue thermogenesis via the gut-brain axis in rats.

Authors:  Jean-Philippe Krieger; Ellen Paula Santos da Conceição; Graciela Sanchez-Watts; Myrtha Arnold; Klaus G Pettersen; Mazher Mohammed; Salvatore Modica; Pius Lossel; Shaun F Morrison; Christopher J Madden; Alan G Watts; Wolfgang Langhans; Shin J Lee
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2018-05-30       Impact factor: 3.619

3.  Dietary Cyanidin-3-Glucoside Attenuates High-Fat-Diet-Induced Body-Weight Gain and Impairment of Glucose Tolerance in Mice via Effects on the Hepatic Hormone FGF21.

Authors:  Lili Tian; Hongmei Ning; Weijuan Shao; Zhuolun Song; Yasaman Badakhshi; Wenhua Ling; Burton B Yang; Patricia L Brubaker; Tianru Jin
Journal:  J Nutr       Date:  2020-08-01       Impact factor: 4.798

4.  Intestinal FFA3 mediates obesogenic effects in mice on a Western diet.

Authors:  Kristen R Lednovich; Chioma Nnyamah; Sophie Gough; Medha Priyadarshini; Kai Xu; Barton Wicksteed; Sidharth Mishra; Shalini Jain; Joseph L Zapater; Hariom Yadav; Brian T Layden
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-07-20       Impact factor: 5.900

5.  Reduced somatostatin signalling leads to hypersecretion of glucagon in mice fed a high-fat diet.

Authors:  Joely A Kellard; Nils J G Rorsman; Thomas G Hill; Sarah L Armour; Martijn van de Bunt; Patrik Rorsman; Jakob G Knudsen; Linford J B Briant
Journal:  Mol Metab       Date:  2020-05-21       Impact factor: 7.422

6.  Suppression of Glucagon-Like Peptide-1 Release by Inhibition of Intestinal NLRP3 Inflammasome Activation in Asc-/- and Nlrp3-/- Mice.

Authors:  Yu Chen; Jason Kidd; Owais M Bhat; Xinxu Yuan; Jinni Hong; Xingxiang He; Pin-Lan Li
Journal:  Front Physiol       Date:  2019-10-01       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.